Drugs /
al102
Back to Drugs List
Overview
Clinical Trials
Al102 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating al102, 1 is phase 2/phase 3 (1 open).
Desmoid-type fibromatosis is the most common disease being investigated in al102 clinical trials [2].
Drug Details
Drug Target(s) [2]:
NOTCH1, NOTCH2, NOTCH3, NOTCH4
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.
